collagen solubilized in 0.5 ml 0.1 M acetic acid, and emulsified in 0.5 ml incomplete Freund's adjuvant (2), or 0.25 mg ovalbumin (grade V; Sigma Chemical Co., St. Louis, MO) solubilized in 0.5 ml 0.9% NaC1 and emulsified in 0.5 ml complete Freund's adjuvant (12) . To stimulate lymph node hypertrophy for experiments requiring nonsensitized cells, rats were injected intradermally with 0.5 ml of 0.9% NaC1 emulsified in 0.5 ml of incomplete Freund's adjuvant (12) .
Cell Preparation. Lymph node cells (LNC) were obtained at sacrifice 14-21 d after antigen injection, and subjected to Ficoll-Hypaque centrifugation to facilitate removal of nonviable cells (12) . Nylon wool-passaged LNC and plastic-adherent LNC (17) were used as sources of T cell-enriched and monocyte/macrophage-enriched populations, respectively. <1.5% of the nylon wool-eluted population showed positive staining using a fluorescein-conjugated goat anti-rat gamma globulin (E.Y. Pharmaceuticals, San Mateo, CA) (18) , whereas >95% of the plastic-adherent cells were positive by esterase staining (17) . Type II collagen-coupled spleen cells, which are capable of inducing antigen-specific delayed hypersensitivity when injected subcutaneously, were prepared using ethylcarbodiimide (16) .
Cultures. LNC were cultured in Corning 25200 tubes (Corning Glass Works, Corning, NY) at a density of 107 cells/ml in medium 199 (Microbiological Associates), supplemented with penicillin-streptomycin (100 U and 100 ug/ml, respectively), buffered with 20 mM Hepes solution (Gibco Laboratories, Grand Island, NY), and made to contain 2% heatinactivated fetal calf serum (Lot 3656; IBL Tissue Culture Products, Rockville, MD), for 48 h at 37°C in a humidified atmosphere containing 95% air and 5% CO2 in the presence or absence of concentrations of concanavalin A (Con A), phytohemagglutinin-M (PHA), or antigen found to be optimal for the generation of rat leukocyte inhibitory factor (LIF) (12) . T cell-and monocyte-enriched populations were cultured under these conditions at densities of 107 and 105 cells/ml, respectively. Cell viability (12) exceeded 95% at culture onset. After 48 h, supernatants were pooled, clarified by centrifugation (12,000 g for 20 min), dialyzed at 4°C against 0.9% NaCl and water for an additional 48 h, and concentrated to a volume of ~1.0 ml per 109 cells by vacuum dialysis or lyophilization. Vacuumdialyzed material was tested immediately, and lyophilized material was stored at -20°C (12) .
Establishment of Antigen-reactive T Cell Lines. T cell lines were established using the method of Ben-Nun et al. (19) . LOU-M or -C LNC were obtained 7-10 d postimmunization with type II collagen or ovalbumin and suspended at a density of 5 x 106 cells/ml in Dulbecco's modified Eagle's medium (Microbiological Associates), supplemented with 1% fresh rat serum, 2-mercaptoethanol (5 x 10 -5 M), penicillin-streptomycin, and Hepes. LNC were cultured in 100-ram petri dishes (6 ml/dish) with antigen (12) . After 72 h of incubation, the cells were harvested and the lymphoblasts separated by centrifugation using a discontinuous Ficoll gradient (19) . A fraction containing >90% lymphoblasts was found consistently in the interface between densities of 1.06 and 1.05 g/ml. These cells were recovered by pipetting, washed twice, and cultured at a density of 2 x 105 cells/ml in Dulbecco's modified Eagle's medium supplemented with 20% (vol/vol) of supernatant containing interleukin 2 (IL-2), 10% horse serum (Gibco Laboratories), 2-mercaptoethanol, nonessential amino acids, sodium pyruvate, antibiotics, and Hepes, without added antigen (10 ml/dish) (20) . The IL-2-containing supernatant was prepared using Con Astimulated DBA/2 splenocytes (20) . The isolated lymphoblasts that were propagated represented ~ 1% of the starting LNC population.
After 7 d, cells undergoing further selection were harvested and resuspended in the culture medium at a density of 2 x 10 "~ cells/ml together with 107 cells/ml irradiated (1,500 rad) syngeneic accessory cells (from the spleen of naive rats) and antigen (collagen or ovalbumin). After 72 h of incubation, the cells were collected, washed, and applied to a Ficoll-Hypaque gradient to isolate the viable lymphoblasts (12) . The lymphoblasts were resuspended in propagation culture medium (2 × 105 cells/ml) and reseeded (10 ml/dish). After 3-4 d of incubation, the cells were harvested and restimulated with antigen as described above. Supernatants used in this study were collected on either day 20 or 56, which was at the end of an antigen-stimulation cycle. T cell membrane markers were identified as described (18) , using the murine monoclonals, W3/13, W3/25, and OX8 (Accurate Chemical and Scientific Corp., Westbury, NY) and fluorescein-conjugated F(ab')2 fragments of goat anti-mouse lgG (Fc fragment-specific) (Cappel Laboratories, Cochranville, PA).
Thymidine Incorporation Assay. Proliferation responses of line cells to Con A and antigen stimulation were measured by a thymidine incorporation technique adapted from one used previously (10, 13) . Line cells were incubated in round-bottomed microtiter plates in quadruplicate wells. Each well contained 2.5 X 104 cells plus 106 accessory cells consisting of irradiated (1,500 rad) syngeneic spleen cells in 0.2 ml Dulbecco's modified Eagle's medium with 1% fresh rat serum in the presence or absence of antigen/mitogen at described concentrations (12, 13) . After 48 h of incubation, cells in each welt were pulsed with 1 uCi [SH]thymidine (sp act, 5.0 Ci/mM; Amersham Corp., Arlington Heights, IL), and incorporation was measured 18 h later (21) . Results are expressed as a stimulation index, calculated as (mean cpm with antigen or Con A)/(mean cpm without antigen or mitogen).
Gel Filtration. Lyophilized supernatant material was fractionated on a calibrated column (2.5 × 100 cm) containing Sephadex G-100 (Pharmacia Fine Chemicals, Piscataway, N J) and was subsequently processed as described (12) .
Affinity Chromatography. Supernatant material, derived from serum-containing cultures of nylon wool-purified cells or line cells, was depleted of albumin using the method of Travis et al. (22) . 40 mg of lyophilized crude supernatant material was solubilized in 0.05 M Tris-HC1 with 0.1 M KCI, pH 7.0, and applied to a preequilibrated 0.9 x 30 cm column containing Blue-Sepharose CL-6B (BS) (Pbarmacia Fine Chemicals). Fractions of unbound material with an optical density at 280 nm (OD2s0) of >0.05 were pooled (BS peak I). Bound material, including albumin, was eluted with 0.05 M Tris-HC1 and 0.2 M NaSCN, pH 8.0 (BS peak II). Both pools were vacuum dialyzed to about one twentieth their original volume. Depletion efficiency was assessed by radial immunodiffusion, using 1.5% agarose containing a 1:50 dilution of rabbit anti-horse albumin (Cappel Laboratories) or rabbit anti-bovine albumin (Cappel Laboratories), where appropriate. Up to 96% of the albumin was removed from BS peak I by this procedure.
For the final affinity isolation, collagen was linked to CNBr-activated Sepharose 4 B (Pharmacia Fine Chemicals), using the method of Stuart et al. (6) . Once the ligand (type 1 or II collagen) had been bound and the gel reequilibrated with the coupling buffer (0.01 M phosphate-buffered saline with 0.5 M NaCl), 4 ml of BS peak I in phosphate-buffered saline was added to the gel and incubated overnight at 4°C with rocking. A 1 x 6 cm column was filled with the gel, washed with phosphate-buffered saline until the OD280 was <0.01, and fractions were pooled (CNBr peak I). A 0.2 M glycine-HC1 wash, pH 2.8, was pumped onto the column and allowed to remain for 3 h before eluting. These latter fractions were also pooled (CNBr peak II). Elution profiles were monitored at OD2s0 and concentrations determined by the Bio-Rad protein assay (Bio-Rad Laboratories, Richmond, CA), with bovine serum albumin as a standard (23) . Both pools were dialyzed for 48 h against distilled water, lyophilized, and stored at -20°C.
SDS-PAGE. Discontinuous SDS-PAGE was performed as described by Laemmli (24).
All samples were run under reduced conditions using 2-mercaptoethanol. 10% polyacrylamide, 1.5-mm-thick slab gels were stained by a silver nitrate method, which detects quantities of protein of ~ 10 ng (25) . Relative molecular weight (Mr) was determined using the following Bio-Rad protein standards: phosphorylase b (92,500), bovine serum albumin (66,200), ovalbumin (50,000 and 45,000), carbonic anhydrase (31,000), and soybean trypsin inhibitor (21,500).
lmmunoglobulin Preparation. Material enriched for Ig was prepared by ammonium sulfat e precipitation (16) of pooled serum, obtained at sacrifice from the rats that developed collagen arthritis, or from immunoiogically naive rats, and stored at -20°C. The IgG antibody titer to nativ e type II collagen was measured by an enzyme-linked immunosorbent assay (26) .
Intraarticular Injections.
Crude or G-100-fractionated supernatant and lg-enriched material were resuspended in Hanks' balanced salt solution (Microbiological Associates) at a ratio of 1 :I (vol/vol). Protein concentrations of the crude supernatants were ~700 mg-percent, as measured by the Lowry technique (27) . Affinity-purified supernatant material was resuspended in Hanks' balanced salt solution at a concentration of ~<10 mgpercent protein. Suspensions were membrane (0.45 ~tm)-sterilized. Under aseptic conditions, 200 ~tl of the crude or G-100 suspension was injected through the avascular region of the infrapatellar ligament (28) into one knee ofa syngeneic naive rat, lightly anesthetized with ether, using a 26-gauge needle. For affinity-purified supernatants, 100 ul was injected.
Arthritis Assessments. After knee injection, rats were evaluated at least every other day for overt clinical signs of arthritis, i.e., a limping gait or obvious knee-joint swelling. Unless specified, rats were sacrificed 7 d postinjection. Synovial tissue overlying the infrapatellar fat pad and the contiguous margins of the patellar and/or tibial cartilage were removed and blocked in paraffin; multiple 5-7-t~m-thick sections were obtained and either stained with hematoxylin and eosin, or processed for immunofluorescence (28) . Based upon morphologic studies in collagen arthritis (2, 4, 28, 29) , and a method used by Andreis et al. (30) in a rabbit-synovitis model, a scoring system was devised for the hematoxylin and eosin-stained slides to reflect (a) the magnitude of diffuse synovial membrane thickening (<5 cell layers thick --0; 5-10 cell layers = 1; 10-15 cell layers = 2; >15 cell layers = 3), and (b) the degree of inflammatory cell (mononuclear cells and polymorphonuclear leukocytes) infiltration and neovascularization in the subsynovial layers (absent --0; minimal --1; moderate = 2; marked --3). Each of the two categories was assigned an integer, resulting in a maximum histologic score of six. Slides were read by the same observer, who was unaware of the experimental group from which the tissue had been obtained; at least five sections were evaluated from each knee.
Physicochemical Treatments. G-100-fractionated supernatant material was exposed to heat, chymotrypsin (a proteinase with broad specificities), and to the serine esterase inhibitor, diisopropylphosphofluoridate (DFP) under conditions previously used to characterize rat LIF (12) . In other experiments, LNC from arthritic rats were cultured in the presence or absence of the endotoxin inactivator, polymyxin B (5 ug/ml) (17), or puromycin, which was used at a nonlethal concentration to block de novo protein synthesis, and removed by methods already described (12) .
L1F Assay. LIF activity in G-100-fractionated material was measured by its ability to inhibit the migration of rat polymorphonuclear leukocytes from capillary tubes. Activity generated by Con A provided a control (12) .
Complement Depletion. Cobra venom factor was prepared and analyzed by the method of Salant et al. (31) . Rats were injected intraperitoneally with 75 and 25 U (32) cobra venom factor on day -1 and day 4, respectively, and intraarticularly with G-100-fractionated material on day 0. Serum C3, measured by Mancini single radial immunodiffusion (33) , was undetectable in all of the rats on day 4, and was <45% of the pretreatment value on day 7, when the rats were sacrificed.
Statistical Analyses. Continuous variables were analyzed by their group means (Student's t-test) and dichotomous variables by their proportionate group frequencies (×2 test). Table I , a significant synovitis developed in the injected knees of W-F rats receiving the crude supernatant material from cultures of LNC or T cells from collagen-arthritic rats stimulated in vitro with native type II collagen. Although ovalbumin is a potent cellular immunogen in rats (12, 16) , injection of supernatants derived from ovalbumin-sensitized LNC did not create this lesion. Only minimal inflammation developed following injection of Ig containing antibodies to type II collagen. The inability of collagen-coupled cells, as well as supernatants derived by culturing LNC from nonartbritic cells or macrophage-enriched cell populations with native type II collagen, to induce appreciable synovitis suggests that collagen carryover does not explain the results of these experiments. (Fig. 1) . The mean histologic score of rats injected with the high-mass fraction was significantly greater than the scores of the other two groups (Table II) . Additional subfractionation of G-100-derived material indicated that AF activity eluted in the 60-70 kD range. Other studies depicted in Table lI showed that AF was an in vitro-synthesized protein, distinct from the similarly sized iymphokine, LIF (12), and not inactivated at 56°C; its arthritogenicity was not likely to be due to contamination by endotoxin. Complement depletion with cobra venom factor did not affect the response of rats to AF.
Results

Identification of Arthritogenic Factor (AF). As shown in
Affinity Pur~cation of AF. The inability of mitogens and antigens other than native type II collagen to generate arthritogenic supernatants (Table I) suggested that AF is an antigen-specific lymphokine. Accordingly, W3/25 + T cell lines were established from collagen-immunized LOU-M and LOU-C rats that reacted FIGURE 1. Swollen knee (viewer's right) 7 d after injection of G-100-enriched AF, compared to the uninjected knee, of a sacrificed rat in which the overlying skin has been reflected. specifically to type II collagen (Table III) . The LOU strain was selected because of its high degree of susceptibility to collagen arthritis observed in other (unpublished) studies. An additional W3/25 + line was established from LOU-M rats immunized with ovalbumin and CFA by stimulation with ovalbumin; this line reacted to antigenic challenge with both ovalbumin and mycobacteria.
The supernatant materials derived from these cell lines were used in the following affinity chromatography studies. The two collagen-reactive T cell lines produced material that bound to type II collagen, and when eluted, gave pronounced AF responses in the knee assay (Table IV) . This antigen-binding AF activity was also generated by nylon wool-nonadberent cells obtained from arthritic W-F and LIS rats. No binding occurred when this material was passaged through an affinity column prepared with type I collagen. The ovalbumin/mycobacteria-reactive line did not produce collagen-binding AF activity. Material enriched for lymphokines by stimulating naive nylon wool-nonadherent cells with Con A and subjecting the supernatant to attempted affinity purification on the type I! collagen column was also devoid of AF activity. This result, as well as the outcome of the ovaibumin/mycobacteria line experiment, make it unlikely that collagen leached off the affinity column produced the inflammation in these studies.
SDS-PAGE under reducing conditions showed a single protein band in tile T cell-derived AF containing materials eluting from the type II collagen-Sepharose column (Fig. 2) . Similar to the molecular mass estimates by gel filtration, the Designations are identical to those described in Table I . * Nine rats developed limping and swelling of the knee. * One rat developed limping and swelling of the knee. Except for those mentioned, none of the other injected knees in these experiments exhibited clinical signs of arthritis. NS, not significant. IL The resistance of AF to DFP indicates that, unlike rat LIF, this protein is not a serine esterase (12) . In addition, this fractionated AF preparation did not possess LIF activity (mean migration inhibition was 8% vs. 54% for AF and Con A-induced LIF, respectively). q Obtained by culturing arthritic LNC with type II collagen in the presence or absence of a drug.
affinity-purified AF from the T cell lines and the nylon wool-purified T cell populations possessed an M,-of 65,000 by SDS-PAGE.
Characteristics of Lesion Induced by AF. Pannus formation, neovascularization,
and synovial infiltrates, consisting predominantly of mononuclear inflammatory cells, some polymorphonuclear leukocytes, and a few eosinophils, were found as early as 48 h after injection of G-100-enriched AF into the knees of W-F rats. Cartilage erosion was also noted at this time (Fig. 3) . Granulomatous areas were occasionally observed in the pannus of day 7 lesions induced with G-100-enriched AF, and immunofluorescence evaluation of synovia during the period 2-7 d postinjection detected abundant fibrin, and rare deposits of Ig and complement (C3). Histologically, the synovitis induced in the knees of LOU rats by the affinity-purified AF was similar to that observed using G-100-enriched material (Fig. 4) . Four knees of LOU-M rats injected 25 d earlier with affinity-purified, line cell-derived AF showed hyperplasia of the synovial lining, mononuclear cell infiltration, subsynovial fibrosis, and occasional granulomas (mean histologic score + SE, 3.6 + 0.3).
Discussion
These data demonstrate the existence of AF, a novel T cell-derived artbritogenic lymphokine, in different strains of rats. At least a portion of this arthritogenic activity is antigen binding, and the ability of native type II collagen to affinity purify AF activity suggests that the responsible species is an antigen-FIGURE 2. Analysis of AF by SDS-PAGE and silver staining under reducing conditions. Lanes represent BS-peak I. A, AF-containing material derived from culturing nylon woolenriched T cells from arthritic LIS rats with type II collagen, diluted for application to the type II collagen-Sepharose column; B, AF-containing material generated by the type II collagen-specific LOU-M T cell line, diluted for column application; C, diluted AF-containing material from the collagen-reactive LOU-C T cell line; D-F, CNBr peak 1 from the LIS, LOU-M, and LOU-C material, respectively; G-l, CNBr peak II (glycine-HCI eluate) from the LIS, LOU-M, and LOU-C material, respectively; J, molecular mass standards. The linear streaks across the gel, including the one in the 60 kD region, are artifacts seen in similar gels run without protein application. 6-12 ~tg of protein was applied to lanes A-F, whereas lanes G-I each received <1 ttg. Development of this gel was prolonged to further demonstrate the absence of contaminating bands in lanes G-I. The analyzed CNBr peak II material from the W-F T cells also had a molecular mass of 65 kD. specific lymphokine reactive with epitopes on type II collagen. T h e ability of puromycin to block the generation o f AF activity in vitro indicates that the protein is not preformed. Further analytic and functional characterization of AF is required to ascertain with greater certainty whether or not AF exists solely as a single 65 kD polypeptide in the rat. Additional work is also necessary to determine whether the bioactivity of AF crosses strains a n d / o r species, or is major histocompatibility complex-restricted.
Most studies o f antigen-specific T cell-derived factors have identified those with suppressor properties (34, 35) , however, analogous factors with promoting activities have been detected in several murine systems (36) (37) (38) . T h e ability of native, but not denatured, type II collagen to stimulate degrees o f AF activity that are readily detectable by bioassay suggests that rat T cells capable of recognizing quarternary epitopes on collagen exist. Previous studies in collagen arthritis have provided additional indirect evidence supporting this proposal (10, 16) . Murine T cells reactive with conformationally dependent determinants on insulin have been identified recently by Glimcher et al. (39) , providing precedence for such a p h e n o m e n o n .
Although the collagen-reactive L O U -M and L O U -C T cell lines differed markedly in their ability to respond in vitro to native type II collagen by thymidine incorporation, both lines generated statistically similar degrees of AF activity. This finding provides evidence that the capacity to proliferate and produce lymphokines in response to antigen stimulation by various T cell lines is dissociable, although the basis for this phenomenon is unclear. The molecular mass of AF differs from the ~20 kD protein, catabolin (40) , which stimulates chondrocytes in vitro, nor is AF identical to the ~15 kD collagen-inducible cytokine, IL-1 or mononuclear cell factor, which heightens release of collagenase and prostaglandin E2 (PGE2) by cultured human synovial cells (I 7) and mediates cartilage matrix degradation (41) . A substance, functionally equivalent to mononuclear cell factor in the synoviocyte assay, can be generated in rats by stimulating naive LNC with Con A, but its Mr by G-100 filtration is 10,000-20,000 (C. E. Brinckerhoffand D. E. Trentham, unpublished data). Another difference from mononuclear cell factor is the inability of G-100 fractionated AF to stimulate release of collagenase and PGE2 in the in vitro rat synoviocyte system (C. E. Brinckerhoff, S. M. Helfgott, and D. E. Trentham, unpublished data).
In rats, the erosive joint lesion that results from intravenous injection of affinity-purified collagen antibodies has been reported (8) to be complementdependent, and to consist largely of polymorphonuclear leukocyte infiltration, rather than pannus formation. The apparent lack of involvement of blood complement and the mononuclear inflammatory cell preponderance in the AF- induced lesion make it unlikely that antibody production by the recipient accounts for the arthritogenic effect of AF.
Although the initiation of collagen arthritis has been postulated (6, 7) to be an antibody-mediated event, the lesion produced by antibody is transient (6) (7) (8) , and is incapable of being sustained by repeated injections (42) . In contrast, a persistent arthritis characterized by extensive synovial hypertrophy can be induced by the intravenous injection of collagen-sensitized spleen cells and LNC in rats (4), or by injection of nylon wool-purified T cells in mice (5) . In the recipients of cells, no serum antibody response to collagen was detected (4, 5) . These passive transfer experiments may indicate that cellular immunity plays a major role in the pathogenesis of collagen arthritis. The recognition of AF identifies a mechanism whereby this process could be subserved.
Increasing attention is being directed to the role of T cells in the pathogenesis of rheumatoid arthritis (1). Lymphokine-like moieties have been identified in the synovial fluid of patients with this disease (43) . An inflammatory synovitis of the knee can be induced in rabbits by repeated intraarticular injections of culture supernatants containing factors generated by homologous LNC sensitized to keyhole limpet hemocyanin (30) . The identification of AF in an animal model, and the presence of cellular sensitivity to collagen in patients with rheumatoid arthritis (44) (45) (46) are consistent with the hypothesis that this lymphokine is an effector molecule in human synovial disease.
Summary
A type II collagen-specific arthritogenic lymphokine has been identified in the rat. Arthritogenic factor (AF) is a 65 kD protein generated in vitro by T cells from rats with collagen arthritis, and it induces an erosive, proliferative synovitis when injected into the knee joint of syngeneic naive recipients. Complement does not appear to be required. These data identify a potential T cell-mediated effector mechanism in this model, and suggest that AF may function in other inflammatory synovial diseases.
